IFNG and neoplasm: Using the same amounts of IFN-γ to treat the tumor cells by the primary activated NK cells’ and sNK cells’ supernatants, we observe a better synergistic lysis of the tumor cells by the sNK cells’ supernatants than those of the primary activated NK cells (Fig. 7).